---
title: "Vernakalant - Atrial Fibrillation"
sidebar: mydoc_sidebar
permalink: db06217-mesh-d001281-1.html
toc: false 
---


Path ID: `DB06217_MESH_D001281_1`
{% include image.html url="images/db06217-mesh-d001281-1.png" file="db06217-mesh-d001281-1.png" alt="db06217-mesh-d001281-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C524581 | Vernakalant | Drug |
| GO:0086013 | Membrane repolarization during cardiac muscle cell action potential | BiologicalProcess |
| UniProt:P22460 | Potassium voltage-gated channel subfamily A member 5 | Protein |
| UniProt:Q9UK17 | Potassium voltage-gated channel subfamily D member 3 | Protein |
| UBERON:0000948 | Heart | GrossAnatomicalStructure |
| MESH:D001281 | Atrial fibrillation | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Vernakalant | DECREASES ACTIVITY OF | Potassium Voltage-Gated Channel Subfamily A Member 5 |
| Potassium Voltage-Gated Channel Subfamily A Member 5 | POSITIVELY REGULATES | Membrane Repolarization During Cardiac Muscle Cell Action Potential |
| Vernakalant | DECREASES ACTIVITY OF | Potassium Voltage-Gated Channel Subfamily D Member 3 |
| Potassium Voltage-Gated Channel Subfamily D Member 3 | POSITIVELY REGULATES | Membrane Repolarization During Cardiac Muscle Cell Action Potential |
| Membrane Repolarization During Cardiac Muscle Cell Action Potential | OCCURS IN | Heart |
| Heart | AFFECTED BY | Atrial Fibrillation |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB06217#BE0004717](https://go.drugbank.com/drugs/DB06217#BE0004717)
  - [https://en.wikipedia.org/wiki/Vernakalant#Mechanism_of_action](https://en.wikipedia.org/wiki/Vernakalant#Mechanism_of_action)
